Feline histoplasmosis: fluconazole therapy and identification of potential sources of Histoplasma species exposure

Jennifer M Reinhart1, Kate S KuKanich, Tracey Jackson

  • 1Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506-5606, USA. jmreinha@vet.k-state.edu

Insights

Fluconazole offers similar outcomes to itraconazole for treating feline histoplasmosis, providing a potentially more affordable option. Indoor cats can be exposed to Histoplasma spores through sources like potted plants and basements.

Area of Science:

  • Veterinary Mycology
  • Feline Infectious Diseases

Background:

  • Feline histoplasmosis is a systemic fungal infection.
  • Itraconazole is a common treatment but can be expensive.
  • Understanding Histoplasma exposure sources in cats is limited.

Purpose of the Study:

  • Compare treatment outcomes of fluconazole versus itraconazole in cats with histoplasmosis.
  • Investigate potential sources of Histoplasma exposure in affected felines.

Main Methods:

  • Retrospective review of medical records for 32 feline patients with confirmed histoplasmosis.
  • Owner telephone interviews for follow-up and exposure history.
  • Comparison of mortality and recrudescence rates between treatment groups.

Main Results:

  • Cats treated with fluconazole (n=17) showed similar mortality and recrudescence rates compared to those treated with itraconazole (n=13).
  • Possible exposure sources identified in indoor cats included potted plants and unfinished basements.

Conclusions:

  • Fluconazole may serve as a viable and potentially cost-effective alternative for treating feline histoplasmosis.
  • Environmental factors like indoor plants and basements may contribute to Histoplasma exposure in cats.

Related Concept Videos